Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Y Aoki

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Clinical Pharmacology and Therapeutics|February 1, 1985
Prophylactic amantadine dose and plasma concentration-effect relationships in healthy adultsF Y Aoki, H G Stiver, D S Sitar, et al.
Biopharmaceutics & Drug Disposition|September 1, 1989
Slow release theophylline disposition and effect in elderly patients with chronic obstructive lung disease: influence of dose formulation and institutionalizationP R Montgomery, F Y Aoki, P A Mitenko, et al.
The Journal of Allergy and Clinical Immunology|April 1, 1987
Immunologic studies in subjects with a serum sickness-like illness after immunization with human diploid cell rabies vaccineR J Warrington, C J Martens, M Rubin, et al.
DICP : the Annals of Pharmacotherapy|February 1, 1991
Prescribing patterns for older heavy drug users living in the communityR E Grymonpre, D S Sitar, P R Montgomery, et al.
Journal of Chronic Diseases|January 1, 1983
Aging and heavy drug use: a prescription survey in ManitobaF Y Aoki, V K Hildahl, G W Large, et al.
Journal of Biological Standardization|January 1, 1989
Intravenous human rabies immunoglobulin for post-exposure prophylaxis: serum rabies neutralizing antibody concentrations and side-effectsF Y Aoki, M E Rubin, A D Friesen, et al.
Lancet (London, England)|June 26, 1976
Human diploid cell strain rabies vaccine. Rapid prophylactic immunisation of volunteers with small dosesG S Turner, F Y Aoki, K G Nicholson, et al.
Comparative Biochemistry and Physiology. B, Comparative Biochemistry|January 1, 1987
Partial characterization of alpha 1-acid glycoprotein isolated from mouse serumR W McGregor, R J Weselake, B A Peltz, et al.
Clinical Pharmacology and Therapeutics|July 1, 1993
Gender and age as factors in the inhibition of renal clearance of amantadine by quinine and quinidineS E Gaudry, D S Sitar, D D Smyth, et al.
Clinical Pharmacology and Therapeutics|July 1, 1989
Nadolol antihypertensive effect and disposition in young and elderly adults with mild to moderate essential hypertensionP A Mitenko, J K McKenzie, D S Sitar, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Clinical Pharmacology and Therapeutics|February 1, 1985
Prophylactic amantadine dose and plasma concentration-effect relationships in healthy adultsF Y Aoki, H G Stiver, D S Sitar, et al.
Biopharmaceutics & Drug Disposition|September 1, 1989
Slow release theophylline disposition and effect in elderly patients with chronic obstructive lung disease: influence of dose formulation and institutionalizationP R Montgomery, F Y Aoki, P A Mitenko, et al.
The Journal of Allergy and Clinical Immunology|April 1, 1987
Immunologic studies in subjects with a serum sickness-like illness after immunization with human diploid cell rabies vaccineR J Warrington, C J Martens, M Rubin, et al.
DICP : the Annals of Pharmacotherapy|February 1, 1991
Prescribing patterns for older heavy drug users living in the communityR E Grymonpre, D S Sitar, P R Montgomery, et al.
Journal of Chronic Diseases|January 1, 1983
Aging and heavy drug use: a prescription survey in ManitobaF Y Aoki, V K Hildahl, G W Large, et al.
Journal of Biological Standardization|January 1, 1989
Intravenous human rabies immunoglobulin for post-exposure prophylaxis: serum rabies neutralizing antibody concentrations and side-effectsF Y Aoki, M E Rubin, A D Friesen, et al.
Lancet (London, England)|June 26, 1976
Human diploid cell strain rabies vaccine. Rapid prophylactic immunisation of volunteers with small dosesG S Turner, F Y Aoki, K G Nicholson, et al.
Comparative Biochemistry and Physiology. B, Comparative Biochemistry|January 1, 1987
Partial characterization of alpha 1-acid glycoprotein isolated from mouse serumR W McGregor, R J Weselake, B A Peltz, et al.
Clinical Pharmacology and Therapeutics|July 1, 1993
Gender and age as factors in the inhibition of renal clearance of amantadine by quinine and quinidineS E Gaudry, D S Sitar, D D Smyth, et al.
Clinical Pharmacology and Therapeutics|July 1, 1989
Nadolol antihypertensive effect and disposition in young and elderly adults with mild to moderate essential hypertensionP A Mitenko, J K McKenzie, D S Sitar, et al.
Pageof 8